Literature DB >> 6310859

Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture.

F Sobrino, M Dávila, J Ortín, E Domingo.   

Abstract

The genetic heterogeneity generated upon passage of foot-and-mouth disease virus (FMDV) in cell culture has been evaluated by T1-oligonucleotide fingerprinting of genomic RNA. Plaque-purified FMDV O-S7 and C-S8 were propagated by serial low multiplicity infections of BHK-21 (c-13) or IBRS-2 (c-26) cells. In independent parallel passage of the same virus, different oligonucleotide variations were fixed in the RNAs. T1-oligonucleotide fingerprinting of RNA from 34 individual viral clones derived from two passaged populations shows an extensive heterogeneity, with some mutations present in only one of the cloned genomes analyzed. Some FMDV variants are phenotypically distinct in that they yield increased progeny in infections of cell monolayers. From the number of variant sequences it can be estimated that each infectious RNA in the population differs in two to eight mutations from the average parental sequence. Thus, passaged FMDV populations consist of a pool of variants, an observation previously made with phage Q beta (E. Domingo, D. Sabo, T. Taniguchi, and C. Weissmann, Cell 13, 735-744, 1978). The FMDV genome must be described as a fluctuating distribution of sequences due to its high mutability. This may be the basis of the extensive genetic and antigenic diversity of this virus in nature.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310859     DOI: 10.1016/0042-6822(83)90258-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  106 in total

1.  Memory in viral quasispecies.

Authors:  C M Ruiz-Jarabo; A Arias; E Baranowski; C Escarmís; E Domingo
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 3.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

4.  Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses.

Authors:  J J Holland; J C de la Torre; D K Clarke; E Duarte
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Molecular epidemiology of the foot-and-mouth disease virus outbreak in the United Kingdom in 2001.

Authors:  Eleanor M Cottam; Daniel T Haydon; David J Paton; John Gloster; John W Wilesmith; Nigel P Ferris; Geoff H Hutchings; Donald P King
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

6.  Foot-and-mouth disease virus O1Lombardy is biochemically related to O2 isolates.

Authors:  O Krebs; H G Berger; W Niedbalski; O Marquardt
Journal:  Virus Genes       Date:  1991-07       Impact factor: 2.332

7.  Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.

Authors:  J C Saiz; M J Gonzalez; M V Borca; F Sobrino; D M Moore
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  Recovery of infectious foot-and-mouth disease virus from suckling mice after direct inoculation with in vitro-transcribed RNA.

Authors:  Eric Baranowski; Nicolás Molina; José Ignacio Núñez; Francisco Sobrino; Margarita Sáiz
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Modeling viral genome fitness evolution associated with serial bottleneck events: evidence of stationary states of fitness.

Authors:  Ester Lázaro; Cristina Escarmís; Esteban Domingo; Susanna C Manrubia
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  The pH Stability of Foot-and-Mouth Disease Virus Particles Is Modulated by Residues Located at the Pentameric Interface and in the N Terminus of VP1.

Authors:  Flavia Caridi; Angela Vázquez-Calvo; Francisco Sobrino; Miguel A Martín-Acebes
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.